47

Listed companies

14

Private companies

101

Insiders

Relation chart of related listed companies: Exact Sciences Corporation

Active Relations

Past Relations

Related listed companies: Exact Sciences Corporation

Active Relations

Past Relations

Relationship chart for related private companies: Exact Sciences Corporation

Active Relations

Past Relations

Related private companies: Exact Sciences Corporation

Genomic Health, Inc.

Medical Specialties

Paradigm Diagnostics, Inc.

Medical Specialties

Wisconsin Technology Council

Miscellaneous Commercial Services

CereVasc, Inc.

Medical Specialties

American Clinical Laboratory Association

Miscellaneous Commercial Services

Kiniksa Pharmaceuticals Ltd.

Pharmaceuticals: Major

Genomic Life, Inc.

Medical/Nursing Services

Flagship Pioneering, Inc.

Investment Managers

Excel Medical Ventures LLC

Investment Managers

YourBio Health, Inc.

Electronic Equipment/Instruments

binx health, inc.

Medical Specialties

Xceed Molecular Corp.

Medical Specialties

Binx Health Ltd.

Miscellaneous Commercial Services

Catalio Capital Management LP

Investment Managers

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Medical Specialties27
Pharmaceuticals: Major10
Biotechnology10
Medical/Nursing Services5
Investment Managers3
Miscellaneous Commercial Services3
Electronic Equipment/Instruments1
Real Estate Development1
Managed Health Care1

Countries of related companies

United States50
United Kingdom3
France2
Canada2
Denmark2
Belgium1
Switzerland1
Logo Exact Sciences Corporation
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Company’s flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Employees
6,950
More about the company